Editorial: New strategies to inhibit cell death in myocardial ischemia-reperfusion injury: how to succeed? Volume II.
作者信息
Kumphune Sarawut, Piot Christophe, Barrere-Lemaire Stéphanie
机构信息
Biomedical Engineering and Innovation Research Centre, Chiang Mai University, Chiang Mai, Thailand.
Biomedical Engineering Institute, Chiang Mai University, Chiang Mai, Thailand.
出版信息
Front Cardiovasc Med. 2023 Aug 8;10:1260800. doi: 10.3389/fcvm.2023.1260800. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: New strategies to inhibit cell death in myocardial ischemia-reperfusion injury: how to succeed? Volume II.社论：抑制心肌缺血再灌注损伤中细胞死亡的新策略：如何取得成功？第二卷。
Front Cardiovasc Med. 2023 Aug 8;10:1260800. doi: 10.3389/fcvm.2023.1260800. eCollection 2023.
2
Editorial: New Strategies to Inhibit Cell Death in Myocardial Ischemia-Reperfusion Injury: How to Succeed?社论：抑制心肌缺血再灌注损伤中细胞死亡的新策略：如何取得成功？
Front Cardiovasc Med. 2022 Jul 4;9:918902. doi: 10.3389/fcvm.2022.918902. eCollection 2022.
3
Involvement of glycogen synthase kinase-3β in liver ischemic conditioning induced cardioprotection against myocardial ischemia and reperfusion injury in rats.糖原合酶激酶-3β参与肝脏缺血预处理诱导的大鼠心肌缺血再灌注损伤的心脏保护作用。
J Appl Physiol (1985). 2017 May 1;122(5):1095-1105. doi: 10.1152/japplphysiol.00862.2016. Epub 2017 Feb 2.
4
Novel Findings and Therapeutic Targets on Cardioprotection of Ischemia/ Reperfusion Injury in STEMI.新型发现与治疗靶点：STEMI 缺血/再灌注损伤的心肌保护作用。
Curr Pharm Des. 2019;25(35):3726-3739. doi: 10.2174/1381612825666191105103417.
5
Reperfusion injury in ST-segment elevation myocardial infarction: the final frontier.ST段抬高型心肌梗死中的再灌注损伤：最后的前沿领域。
Coron Artery Dis. 2017 May;28(3):253-262. doi: 10.1097/MCA.0000000000000468.
6
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.心血管危险因素与心肌缺血/再灌注损伤、预处理及后处理之间的相互作用。
Pharmacol Rev. 2007 Dec;59(4):418-58. doi: 10.1124/pr.107.06002. Epub 2007 Nov 29.
7
Cardioprotective effects of shock wave therapy: A cardiac magnetic resonance imaging study on acute ischemia-reperfusion injury.冲击波疗法的心脏保护作用：一项关于急性缺血再灌注损伤的心脏磁共振成像研究。
Front Cardiovasc Med. 2023 Apr 27;10:1134389. doi: 10.3389/fcvm.2023.1134389. eCollection 2023.
8
Myocardial ischemia and reperfusion.心肌缺血与再灌注
Monogr Pathol. 1995;37:47-80.
9
Combination of necroptosis and apoptosis inhibition enhances cardioprotection against myocardial ischemia-reperfusion injury.坏死性凋亡和凋亡抑制的联合作用增强了对心肌缺血再灌注损伤的心脏保护作用。
J Anesth. 2014 Apr;28(2):235-41. doi: 10.1007/s00540-013-1716-3. Epub 2013 Oct 11.
10
Role of miRNA-1 and miRNA-21 in Acute Myocardial Ischemia-Reperfusion Injury and Their Potential as Therapeutic Strategy.miRNA-1 和 miRNA-21 在急性心肌缺血再灌注损伤中的作用及其作为治疗策略的潜力。
Int J Mol Sci. 2022 Jan 28;23(3):1512. doi: 10.3390/ijms23031512.
本文引用的文献
1
Anti-Protease Activity Deficient Secretory Leukocyte Protease Inhibitor (SLPI) Exerts Cardioprotective Effect against Myocardial Ischaemia/Reperfusion.抗蛋白酶活性缺陷的分泌型白细胞蛋白酶抑制剂（SLPI）对心肌缺血/再灌注具有心脏保护作用。
Biomedicines. 2022 Apr 25;10(5):988. doi: 10.3390/biomedicines10050988.
2
Therapeutic application of chick early amniotic fluid: effective rescue of acute myocardial ischemic injury by intravenous administration.鸡早期羊水的治疗应用：静脉注射有效挽救急性心肌缺血损伤
Cell Regen. 2022 Apr 1;11(1):9. doi: 10.1186/s13619-022-00110-1.
3
Role of epigenetic regulation in myocardial ischemia/reperfusion injury.表观遗传调控在心肌缺血/再灌注损伤中的作用。
Pharmacol Res. 2021 Aug;170:105743. doi: 10.1016/j.phrs.2021.105743. Epub 2021 Jun 26.
4
Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury.重组人分泌型白细胞蛋白酶抑制剂（rhSLPI）的缺血后治疗减轻了心肌缺血/再灌注损伤。
Biomedicines. 2021 Apr 13;9(4):422. doi: 10.3390/biomedicines9040422.
Zotero 插件